Skip to main content
. 2016 May 13;7(4):428–436. doi: 10.1111/1759-7714.12350

Figure 1.

Figure 1

Blinded and randomized detection of epidermal growth factor receptor (EGFR) mutations by electric field‐induced release and measurement assay in saliva collected before surgery from patients with non‐small cell lung cancer: (a) the probe for EGFR exon 19 deletion in saliva; (b) the probe for L858R in saliva; and (c) receiver operating characteristic curves for detecting EGFR exon 19 deletion (area under the curve [AUC] = 1) and L858R mutations (AUC = 1), respectively.